Skip to main content
SpringerLink
Log in

Effect of thrombin inhibitors on positive feedback in the coagulation cascade

  • Published:
Biochemistry (Moscow) Aims and scope Submit manuscript

Abstract

The coagulation cascade is a series of sequential reactions of limited proteolysis of protein factors resulting in generation of thrombin. Thrombin mediates both positive and negative feedback in regulating this cascade by taking part in activation of several factors. Some thrombin inhibitors, by affecting positive feedback, inhibit generation of thrombin itself. In the current study, we used two thrombin inhibitors: argatroban, a low molecular weight reversible competitive inhibitor that binds to the active site, and bivalirudin, a bivalent oligopeptide that blocks the active site and binding center of protein substrates (exosite I). Appearance rate and total amount of thrombin were measured in a thrombin generation assay (TGA) using a fluorescent substrate. We found that argatroban slows the appearance of thrombin and lowers its amount. Bivalirudin also slows appearance of thrombin, but it does not decrease its amount, perhaps because the region being bound to the active site undergoes hydrolysis so that the inhibitor stops binding to thrombin. Many reactions of the coagulation cascade proceed on the surface of phospholipid micelles (PLMs). In the case of argatroban, PLMs do not affect the results of the TGA, whereas for bivalirudin they lower its inhibitory activity. It seems that PLMs stabilize protein complexes (wherein thrombin exosite I is hindered) mediating positive feedback in the coagulation cascade, e.g. complexes of thrombin with factor V and VIII.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AMC:

7-amino-4-methylcoumarin

FII/V/VII/VIII/IX/X/XI/XII/XIII(a):

coagulation factors II/V/VII/VIII/IX/X/XI/XII/XIII (activated)

PLM:

phospholipid micelles

TGA:

thrombin generation assay

References

  1. Macfarlane, R. G. (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier, Nature, 202, 498–499.

    Article  CAS  PubMed  Google Scholar 

  2. Davie, E. W. (2003) A brief historical review of the water-fall/cascade of blood coagulation, J. Biol. Chem., 278, 50819–50832.

    Article  CAS  PubMed  Google Scholar 

  3. Jackson, C. M., and Nemerson, Y. (1980) Blood coagulation, Ann. Rev. Biochem., 49, 765–811.

    Article  CAS  PubMed  Google Scholar 

  4. Page, M. J., and Di Cera, E. (2008) Serine peptidases: classification, structure and function, Cell. Mol. Life Sci., 65, 1220–1236.

    Article  CAS  PubMed  Google Scholar 

  5. Suttie, J. W., and Jackson, C. M. (1977) Prothrombin structure, activation, and biosynthesis, Physiol. Rev., 57, 1–70.

    CAS  PubMed  Google Scholar 

  6. Myles, T., Yun, T. H., Hall, S. W., and Leung, L. L. (2001) An extensive interaction interface between thrombin and factor V is required for factor V activation, J. Biol. Chem., 276, 25143–25149.

    Article  CAS  PubMed  Google Scholar 

  7. Myles, T., Yun, T. H., and Leung, L. L. (2002) Structural requirements for the activation of human factor VIII by thrombin, Blood, 100, 2820–2826.

    Article  CAS  PubMed  Google Scholar 

  8. Von dem Borne, P. A., Meijers, J. C., and Bouma, B. N. (1995) Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis, Blood, 86, 3035–3042.

    Google Scholar 

  9. Sadasivan, C., and Yee, V. C. (2000) Interaction of the factor XIII activation peptide with α-thrombin crystal structure of its enzyme–substrate analog complex, J. Biol. Chem., 275, 36942–36948.

    Article  CAS  PubMed  Google Scholar 

  10. Dahlback, B., and Villoutreix, B. O. (2005) The anticoagulant protein C pathway, FEBS Lett., 579, 3310–3316.

    Article  PubMed  Google Scholar 

  11. Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R., and Hofsteenge, J. (1989) The refined 1.9 Å crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the TyrPro-Pro-Trp insertion segment, EMBO J., 8, 3467.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Fenton, J. W., Olson, T. A., Zabrinski, M. P., and Wilner, G. D. (1988) Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition, Biochemistry, 27, 7106–7112.

    Article  CAS  PubMed  Google Scholar 

  13. Bjork, I., and Lindahl, U. (1982) Mechanism of the anti-coagulant action of heparin, Mol. Cell. Biochem., 48, 161–182.

    Article  CAS  PubMed  Google Scholar 

  14. Fenton, J. W., Witting, J. I., Pouliott, C., and Fareed, J. (1989) Thrombin anion-binding exosite interactions with heparin and various polyanions, Ann. N. Y. Acad. Sci., 556, 158–165.

    Article  CAS  PubMed  Google Scholar 

  15. Lee, C. J., and Ansell, J. E. (2011) Direct thrombin inhibitors, Brit. J. Clin. Pharmacol., 72, 581–592.

    Article  CAS  Google Scholar 

  16. Warkentin, T. E. (2004) Bivalent direct thrombin inhibitors: hirudin and bivalirudin, Best Pract. Res. Clin. Haematol., 17, 105–125.

    Article  CAS  PubMed  Google Scholar 

  17. Berry, C. N., Girardot, C., Lecoffre, C., and Lunven, C. (1994) Effects of the synthetic thrombin inhibitor argatroban on fibrin-or clot-incorporated thrombin: comparison with heparin and recombinant hirudin, Thromb. Haemost., 72, 381–386.

    CAS  PubMed  Google Scholar 

  18. Romisch, J., Diehl, K. H., Hoffmann, D., Krahl-Mateblowski, U., Reers, M., Stuber, W., and Paques, E. P. (1993) Comparison of in vitro and in vivo properties of rhirudin (HBW 023) and a synthetic analogous peptide, Pathophysiol. Haemost. Thromb., 23, 249–258.

    Article  CAS  Google Scholar 

  19. Kikumoto, R., Tamao, Y., Tezuka, T., Tonomura, S., Hara, H., Ninomiya, K., and Okamoto, S. (1984) Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid, Biochemistry, 23, 85–90.

    Article  CAS  PubMed  Google Scholar 

  20. Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., and Fenton, J. D. (1990) Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin, Biochemistry, 29, 7095–7101.

    Article  CAS  PubMed  Google Scholar 

  21. Robson, R., White, H., Aylward, P., and Frampton, C. (2002) Bivalirudin pharmacokinetics and pharmacody-namics: effect of renal function, dose, and gender, J. Clin. Pharm. Ther., 71, 433–439.

    Article  CAS  Google Scholar 

  22. Hemker, H. C., Al Dieri, R., De Smedt, E., and Beguin, S. (2006) Thrombin generation, a function test of the haemostatic-thrombotic system, Thromb. Haemost., 96, 553–561.

    CAS  PubMed  Google Scholar 

  23. Baglin, T. (2005) The measurement and application of thrombin generation, Brit. J. Haematol., 130, 653–661.

    Article  CAS  Google Scholar 

  24. Fischer, A. M., Tapon-Bretaudiere, J., Bros, A., and Josso, F. (1981) Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation, Thromb. Haemost., 45, 51–54.

    CAS  PubMed  Google Scholar 

  25. Nagashima, H. (2002) Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and argatroban I. Effects on thrombin generation, J. Biol. Chem., 277, 50439–50444.

    Article  CAS  PubMed  Google Scholar 

  26. Tanaka, K. A., Szlam, F., Sun, H. Y., Taketomi, T., and Levy, J. H. (2007) Thrombin generation assay and vis-coelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin, Anesth. Analg., 105, 933–939.

    Article  CAS  PubMed  Google Scholar 

  27. Nesheim, M. E., Taswell, J. B., and Mann, K. G. (1979) The contribution of bovine factor V and factor Va to the activity of prothrombinase, J. Biol. Chem., 254, 10952–10962.

    CAS  PubMed  Google Scholar 

  28. Huntington, J. A. (2005) Molecular recognition mechanisms of thrombin, J. Thromb. Haemost., 3, 1861–1872.

    Article  CAS  PubMed  Google Scholar 

  29. Yun, T. H., Baglia, F. A., Myles, T., Navaneetham, D., Lopez, J. A., Walsh, P. N., and Leung, L. L. (2003) Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Iba with thrombin anion-binding exosites I and II, respectively, J. Biol. Chem., 278, 48112–48119.

    Article  CAS  PubMed  Google Scholar 

  30. Witting, J. I., Bourdon, P., Brezniak, D. V., Maragnore, J. M., and Fenton, J. W. (1992) Thrombin-specific inhibition by and slow cleavage of hirulog-1, Biochem. J., 283, 737–743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Cappiello, M., Vilardo, P. G., Del Corso, A., and Mura, U. (1998) Hirunorms, novel hirudin-like direct thrombin inhibitors, Gen. Pharmacol. Vasc. Syst., 30, 565–568.

    Article  CAS  Google Scholar 

  32. DiMaio, J., Gibbs, B., Lefebvre, J., Konishi, Y., Munn, D., Yue, S. Y., and Hornberger, W. (1992) Synthesis of a homologous series of ketomethylene arginyl pseudodipep-tides and application to low molecular weight hirudin-like thrombin inhibitors, J. Med. Chem., 35, 3331–3341.

    Article  CAS  PubMed  Google Scholar 

  33. Macedo-Ribeiro, S., Bode, W., Huber, R., Quinn-Allen, M. A., Kim, S. W., Ortel, T. L., and Fuentes-Prior, P. (1999) Crystal structures of the membrane-binding C2 domain of human coagulation factor V, Nature, 402, 434–439.

    Article  CAS  PubMed  Google Scholar 

  34. Pratt, K. P., Shen, B. W., Takeshima, K., Davie, E. W., Fujikawa, K., and Stoddard, B. L. (1999) Structure of the C2 domain of human factor VIII at 1.5 Å resolution, Nature, 402, 439–442.

    Article  CAS  PubMed  Google Scholar 

  35. Sunnerhagen, M., Forsen, S., Hoffren, A. M., Drakenberg, T., Teleman, O., and Stenflo, J. (1995) Structure of the Ca2+-free GLA domain sheds light on membrane binding of blood coagulation proteins, Nat. Struct. Mol. Biol., 2, 504–509.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Chemistry, Lomonosov Moscow State University, 119991, Moscow, Russia

    N. B. Ustinov, E. G. Zav’yalova & A. M. Kopylov

  2. Apto-pharm LLC, 115446, Moscow, Russia

    E. G. Zav’yalova & A. M. Kopylov

Authors
  1. N. B. Ustinov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. G. Zav’yalova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. Kopylov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. B. Ustinov.

Additional information

Original Russian Text © N. B. Ustinov, E. G. Zav’yalova, A. M. Kopylov, 2016, published in Biokhimiya, 2016, Vol. 81, No. 3, pp. 361–368.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ustinov, N.B., Zav’yalova, E.G. & Kopylov, A.M. Effect of thrombin inhibitors on positive feedback in the coagulation cascade. Biochemistry Moscow 81, 242–248 (2016). https://doi.org/10.1134/S0006297916030068

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0006297916030068

Key words

Search

Navigation